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Background: Full prescription-drug coverage after MI increases medication adherence and reduces rates of major vascular events. Little is known 
about the relative impact of enhanced drug coverage post-MI in patients undergoing PCI.
Methods: We compared the effect of full prescription coverage versus usual prescription coverage on cost, adherence, and clinical outcomes 
in 5855 MI patients based on having undergone PCI in the randomized MI FREEE Trial. Cox proportion models were used to adjust for baseline 
differences and formal interaction terms tested for differential outcomes by randomized study assignment.
Results: The 3903 (67%) subjects who underwent PCI were younger, more likely male, and less likely to have a history of hypertension, prior 
MI, CHF, stroke, or diabetes than patients not undergoing PCI. Among PCI patients, full coverage increased adherence to secondary preventive 
medications (p<0.001 for all), reduced rates of fatal or non-fatal MI, unstable angina, stroke, or CHF (HR 0.74 [0.63-0.86], p<0.001) and decreased 
patient out-of-pocket spending for drugs and other medical services (p<0.001). There were no significant interactions between PCI status, study 
assignment, and outcomes (Fig).
Conclusion: As compared with usual prescription coverage, full prescription drug coverage significantly increases medication adherence, reduces 
patient costs, and improves clinical outcomes. Post-MI patients are likely to benefit from this strategy regardless of whether they undergo PCI.
 
